This disclosure relates to 5-MeO-PiPT
chloride, crystalline 5-MeO-PiPT
chloride, 4-methylcarbonato-DPT
chloride, crystalline 4-methylcarbonato-DPT chloride, NiPT fumarate, crystalline NiPT fumarate, NiPT chloride, crystalline NiPT chloride, MDPT
iodide, crystalline MDPT
iodide, 5-HT, crystalline 5-HT, 5-HT chloride
butanol solvate, crystalline 5-HT chloride
butanol solvate, N-cyclohexyltryptammonium fumarate, crystalline N-cyclohexyltryptammonium fumarate, 5-HO-TET
iodide, crystalline 5-HO-TET iodide, TALT iodide, crystalline TALT iodide, 4-(4-chlorobenzoato)-DPT chloride, crystalline 4-(4-chlorobenzoato)-DPT chloride, and specific crystalline forms thereof, including crystalline form 1 of 5-MeO-PiPT chloride, crystalline form 1 of 4-methylcarbonato-DPT chloride, crystalline form 1 of NiPT fumarate, crystalline form 1 of NiPT chloride, crystalline form 1 of MDPT iodide, crystalline form 1 of 5-HT, crystalline form 1 of 5-HT chloride
butanol solvate, crystalline form 1 of N-cyclohexyltryptammonium fumarate, crystalline form 1 of 5-HO-TET iodide, crystalline form 1 of TALT iodide, and crystalline form 1 of 4-(4-chlorobenzoato)-DPT chloride, to compositions containing the same, and to methods of treatment using them.